BioNano Genomics Inc vs Remitly Global Inc — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Remitly Global Inc trades at $23.73 (market cap $4.97B). The key difference: Remitly Global Inc is far larger — about 363.8× BioNano Genomics Inc's market cap, and Remitly Global Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | RELY | |
|---|---|---|
Market Cap | $13.66M | $4.97B |
Sector | Health | Technology |
52-Week High | $4.92 | $25.93 |
52-Week Low | $1.06 | $12.20 |
Enterprise Value | $16.26M | $4.33B |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →